| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,018 |
6,122 |
$808K |
| G0378 |
Hospital observation service, per hour |
1,248 |
1,041 |
$782K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,387 |
2,930 |
$544K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
5,048 |
4,550 |
$288K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,906 |
1,869 |
$285K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,295 |
3,432 |
$284K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,926 |
2,643 |
$194K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,908 |
3,503 |
$187K |
| 80053 |
Comprehensive metabolic panel |
20,342 |
15,464 |
$164K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,863 |
2,322 |
$136K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,736 |
16,302 |
$123K |
| 80061 |
Lipid panel |
5,149 |
4,274 |
$115K |
| 88342 |
|
1,013 |
726 |
$106K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,773 |
1,211 |
$90K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,775 |
1,213 |
$90K |
| 36415 |
Collection of venous blood by venipuncture |
17,208 |
13,313 |
$87K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,193 |
4,210 |
$80K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,634 |
2,889 |
$57K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,338 |
775 |
$52K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,663 |
3,517 |
$48K |
| 82728 |
|
1,711 |
1,396 |
$44K |
| 88142 |
|
1,999 |
1,261 |
$40K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,239 |
3,092 |
$39K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,242 |
801 |
$39K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,157 |
798 |
$34K |
| 82607 |
|
1,162 |
939 |
$31K |
| 84439 |
|
1,795 |
1,478 |
$30K |
| 86803 |
|
1,153 |
794 |
$23K |
| 85027 |
|
1,965 |
1,557 |
$20K |
| 83655 |
|
812 |
679 |
$20K |
| 82746 |
|
915 |
731 |
$18K |
| 87081 |
|
1,506 |
1,201 |
$17K |
| 83540 |
|
1,347 |
1,060 |
$16K |
| 80050 |
General health panel |
1,834 |
1,633 |
$15K |
| 87186 |
|
1,345 |
933 |
$15K |
| 83735 |
|
6,960 |
4,989 |
$14K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
378 |
269 |
$14K |
| 87077 |
|
1,433 |
969 |
$13K |
| 86787 |
|
809 |
506 |
$13K |
| 83550 |
|
898 |
677 |
$13K |
| 87070 |
|
1,084 |
739 |
$11K |
| 85610 |
|
2,927 |
2,348 |
$11K |
| 81001 |
|
5,844 |
4,980 |
$10K |
| 84466 |
|
321 |
294 |
$10K |
| 87340 |
|
1,161 |
729 |
$10K |
| 82570 |
|
1,067 |
865 |
$10K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,018 |
975 |
$9K |
| 86140 |
|
890 |
702 |
$9K |
| 80074 |
|
111 |
77 |
$8K |
| 83970 |
|
131 |
99 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
441 |
142 |
$8K |
| 86592 |
|
1,484 |
1,047 |
$8K |
| 86850 |
|
1,248 |
752 |
$8K |
| 86762 |
|
877 |
519 |
$8K |
| 84480 |
|
376 |
309 |
$8K |
| 84702 |
|
380 |
245 |
$7K |
| 86703 |
|
640 |
382 |
$6K |
| 82043 |
|
534 |
470 |
$6K |
| 85652 |
|
1,134 |
911 |
$6K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,444 |
1,111 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
400 |
312 |
$5K |
| 80081 |
|
27 |
25 |
$5K |
| 86780 |
|
731 |
404 |
$5K |
| 82950 |
|
736 |
550 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
221 |
216 |
$5K |
| 85730 |
|
1,698 |
1,447 |
$4K |
| 84153 |
|
145 |
116 |
$4K |
| 84403 |
|
100 |
80 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,099 |
904 |
$4K |
| 86038 |
|
200 |
162 |
$4K |
| 84550 |
|
496 |
377 |
$4K |
| 83880 |
|
1,272 |
1,099 |
$4K |
| 84484 |
|
4,113 |
3,252 |
$4K |
| 82105 |
|
184 |
132 |
$4K |
| 94060 |
|
27 |
27 |
$3K |
| 85018 |
|
704 |
593 |
$3K |
| 85014 |
|
693 |
586 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
2,233 |
2,027 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,849 |
1,669 |
$3K |
| 87147 |
|
540 |
263 |
$3K |
| 83516 |
|
144 |
106 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
19 |
14 |
$3K |
| 86900 |
|
1,270 |
780 |
$3K |
| 86901 |
|
1,265 |
775 |
$3K |
| 87205 |
|
326 |
265 |
$3K |
| 84156 |
|
400 |
308 |
$3K |
| 82784 |
|
171 |
83 |
$2K |
| 80076 |
|
117 |
102 |
$2K |
| 94762 |
|
15 |
12 |
$2K |
| 86480 |
|
16 |
12 |
$2K |
| 84100 |
|
662 |
501 |
$2K |
| 94729 |
|
39 |
37 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
207 |
181 |
$2K |
| 87507 |
|
23 |
13 |
$2K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,919 |
1,405 |
$2K |
| 86003 |
|
38 |
12 |
$2K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
47 |
13 |
$2K |
| 83615 |
|
113 |
101 |
$1K |
| 83690 |
|
1,883 |
1,678 |
$1K |
| 82962 |
|
283 |
151 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
16 |
13 |
$858.47 |
| 82948 |
|
290 |
151 |
$753.45 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
396 |
369 |
$728.71 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
268 |
258 |
$673.87 |
| 84146 |
|
14 |
13 |
$643.92 |
| 83001 |
|
13 |
12 |
$617.40 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13 |
12 |
$564.99 |
| 84703 |
|
31 |
28 |
$523.50 |
| 81003 |
|
283 |
264 |
$462.43 |
| 71045 |
Radiologic examination, chest; single view |
1,898 |
1,695 |
$445.69 |
| 86431 |
|
51 |
39 |
$425.68 |
| 94727 |
|
24 |
24 |
$273.92 |
| 82550 |
|
525 |
458 |
$270.56 |
| 87088 |
|
16 |
12 |
$214.30 |
| 82150 |
|
39 |
38 |
$201.99 |
| 87075 |
|
17 |
12 |
$190.62 |
| 86706 |
|
30 |
12 |
$138.83 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
634 |
409 |
$102.01 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,548 |
1,289 |
$95.80 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
47 |
27 |
$69.52 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,026 |
2,364 |
$48.34 |
| J1644 |
Injection, heparin sodium, per 1000 units |
376 |
170 |
$46.88 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
677 |
602 |
$38.72 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,127 |
871 |
$16.94 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,983 |
1,544 |
$10.87 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
363 |
197 |
$8.27 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
231 |
173 |
$1.82 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
38 |
28 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
73 |
50 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
51 |
25 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
349 |
235 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
15 |
13 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
121 |
84 |
$0.00 |
| 81329 |
|
41 |
12 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
145 |
71 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
982 |
810 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
431 |
357 |
$0.00 |
| 87040 |
|
284 |
247 |
$0.00 |
| 83605 |
|
611 |
513 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
140 |
79 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
71 |
49 |
$0.00 |
| 85379 |
|
43 |
38 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
12 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
15 |
15 |
$0.00 |
| 82553 |
|
34 |
33 |
$0.00 |